Objective To compare the efficacy of different statin treatments by intensity on levels of non-
high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular …

Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y
enfermedad cardiovascular aterosclerótica SciELO - Scientific Electronic Library Online vol.92 …

Background Findings of large randomised trials have shown that lowering LDL cholesterol
with statins reduces vascular morbidity and mortality rapidly, but limited evidence exists …

Importance Statins are drugs of choice in treating hyperlipidemia and preventing or reducing
cardiovascular diseases. Purpose Explore statins utilization and expenditure trends in the …

Background Cardiovascular diseases are the leading cause of death in the United States,
yet a significant proportion of adults at high risk remain undetected by standard screening …

Background Triglyceride-rich lipoproteins particles (TRLP) and low density lipoprotein
particles (LDLP) vary in size. Their association with β-cell function is not well described. We …

Objective The aim of this article is to assess the risk and potential mechanisms of
cardiovascular adverse events in patients treated with nilotinib or imatinib by conducting a …

Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled
worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol …

Atherosclerosis is a chronic inflammatory disease of the arterial vessel wall and underlies
the development of cardiovascular diseases, such as myocardial infarction and ischemic …

Background Polygenic risk score for coronary artery disease (CAD-PRS) improves precision
in assessing the risk of cardiovascular diseases and is cost-effective in preventing …